Molecular Recognition during pre-mRNA Splicing
Molecular Recognition during pre-mRNA Splicing
批准号:
8296694
负责人:
CLARA KIELKOPF
金额:
$36.64万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2004
资助国家:
美国
项目状态:
已结题
起止时间:
2004-07-01 至 2014-05-31
关键词:
3&apos Splice SiteATP HydrolysisATP phosphohydrolaseAddressAdenosineAdoptedAffinityArchitectureArginineBindingCell Differentiation processCollaborationsComplexConsensusConsensus SequenceDevelopmentDimensionsEnsureEukaryotaExcisionFluorescenceGene ExpressionGoalsHealthHereditary DiseaseHumanHuman GeneticsIntronsInvestigationLaboratoriesLeadMalignant NeoplasmsMapsMetabolic DiseasesModelingMolecularMolecular ChaperonesMolecular ConformationMyotonic DystrophyPhosphorylationPhosphorylation SitePositioning AttributeProcessProteinsRNARNA SplicingReactionRecruitment ActivityResolutionRoentgen RaysRoleSF1SerineSideSignal TransductionSiteSite-Directed MutagenesisSmall Nuclear RNASolutionsSourceSpliceosome Assembly PathwaySpliceosomesStagingStructureSurfaceTestingThermodynamicsTranscriptU2 Small Nuclear RibonucleoproteinVariantWaterWorkX-Ray CrystallographyYeastsabstractingacrosome stabilizing factoranalogbasehuman diseaseinterestleukemiamRNA Precursormacromolecular assemblymolecular recognitionnervous system disordernovelprotein protein interactionpublic health relevancesynchrotron radiationthree dimensional structure
中文摘要
摘要:
前体mRNA的剪接为细胞分化提供了转录物多样性的主要来源,
发展众所周知,该过程需要拼接机(spliceosome)组成,
约100种蛋白质和5种小核(sn)RNA。剪接体组装的早期阶段
前mRNA剪接位点是人类遗传疾病中经常出错的关键调控步骤
和癌症。然而,剪接体究竟如何选择和切除正确的剪接位点,
在数以千计的竞争前mRNA序列中,
分子水平。因此,本提案的总体目标是了解顺序的三个-
在剪接体的早期阶段指导3'剪接位点选择的三维相互作用
activation.
必需剪接因子U2 AF和SF 1的复合物识别前mRNA
序列邻近3'剪接位点,并反过来稳定核心剪接体的缔合。
前体mRNA通过U2 AF的丝氨酸-丝氨酸(RS)区域接触,以及U2 AF相关的
ATP酶UAP 56是完成这一任务所必需的。该提案的具体目标是解决
以下是关于前体mRNA剪接关键早期阶段的核心问题:
(1)U2 AF通过什么方式识别不同的剪接位点?
(2)SF 1通过什么方式增强U2 AF对剪接位点的识别?
(3)U2 AF通过什么方式招募UAP 56,反过来,UAP 56的行动是什么
在U2 AF的剪接位点上
(4)RS区通过什么方式促进剪接体snRNAs与
前体mRNA
我们已在实现这些目标方面取得重大进展,包括:(i)确定三项目标:
结合剪接位点的U2 AF的三维结构,(ii)评估热力学和
SF 1结构域对U2 AF结合的结构贡献,以及(iii)表征RNA
RS域的相互作用。这些研究将大大推进我们对这一点的理解
基因表达的基本步骤。
英文摘要
Abstract:
Splicing of pre-mRNAs provides a major source of transcript diversity for cell differentiation and
development. It is known that this process requires a splicing machine (spliceosome) composed
of ~100 proteins and 5 small nuclear (sn)RNAs. The early stages of spliceosome assembly on
pre-mRNA splice sites are key regulated steps that often go awry in human genetic diseases
and cancers. Yet, exactly how the spliceosome selects and excises the correct splice sites from
amidst thousands of competing pre-mRNA sequences remains poorly understood at the
molecular level. Hence, the overall goal of this proposal is to understand the sequential three-
dimensional interactions that guide 3' splice site selection in the early stages of spliceosome
activation.
A complex of the essential splicing factors U2AF and SF1 recognizes pre-mRNA
sequences adjacent the 3' splice site, and in turn stabilizes association of the core spliceosome.
Pre-mRNA contacts by an arginine-serine (RS) region of U2AF, and the U2AF-associated
ATPase UAP56, are required to accomplish this task. Specific aims of this proposal address the
following central questions concerning the critical early stages of pre-mRNA splicing:
(1) By what means does U2AF recognize diverse splice sites?
(2) By what means does SF1 enhance splice site recognition by U2AF?
(3) By what means does U2AF recruit UAP56, and in turn, what is the action of UAP56
on U2AF at the splice site?
(4) By what means does an RS region promote association of spliceosomal snRNAs with
the pre-mRNA?
We have already made significant advances towards these aims by (i) determining three-
dimensional structures of U2AF bound to splice sites, (ii) evaluating thermodynamic and
structural contributions of SF1 domains to U2AF binding, and (iii) characterizing RNA
interactions by RS domains. These studies will significantly advance our understanding of this
fundamental step of gene expression.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Structural Control of Human Co-factors for Retroviral Gene Expression
-
批准号:9008671
-
项目类别:
-
资助金额:$29.55万
-
财政年份:2016
-
负责人:CLARA KIELKOPF
-
依托单位:
Structural Control of Human Co-factors for Retroviral Gene Expression
-
批准号:9341781
-
项目类别:
-
资助金额:$8.45万
-
财政年份:2016
-
负责人:CLARA KIELKOPF
-
依托单位:
MOLECULAR RECOGNITION DURING PRE-MRNA SPLICING
-
批准号:8362295
-
项目类别:
-
资助金额:$0.22万
-
财政年份:2011
-
负责人:CLARA KIELKOPF
-
依托单位:
PRE-MRNA SPLICE SITE RECOGNITION IN HUMAN DISEASE
-
批准号:8363522
-
项目类别:
-
资助金额:$0.57万
-
财政年份:2011
-
负责人:CLARA KIELKOPF
-
依托单位:
PRE-MRNA SPLICE SITE RECOGNITION IN HUMAN DISEASE
-
批准号:8362272
-
项目类别:
-
资助金额:$0.03万
-
财政年份:2011
-
负责人:CLARA KIELKOPF
-
依托单位:
BIAcore T100 for research and drug discovery in Rochester
-
批准号:7792943
-
项目类别:
-
资助金额:$36.48万
-
财政年份:2010
-
负责人:CLARA KIELKOPF
-
依托单位:
PRE-MRNA SPLICE SITE RECOGNITION IN HUMAN DISEASE
-
批准号:8171502
-
项目类别:
-
资助金额:$0.54万
-
财政年份:2010
-
负责人:CLARA KIELKOPF
-
依托单位:
PRE-MRNA SPLICE SITE RECOGNITION IN HUMAN DISEASE
-
批准号:8170273
-
项目类别:
-
资助金额:$0.1万
-
财政年份:2010
-
负责人:CLARA KIELKOPF
-
依托单位:
MOLECULAR RECOGNITION DURING PRE-MRNA SPLICING
-
批准号:8170296
-
项目类别:
-
资助金额:$0.03万
-
财政年份:2010
-
负责人:CLARA KIELKOPF
-
依托单位:
PRE-MRNA SPLICE SITE RECOGNITION IN HUMAN DISEASE
-
批准号:7955565
-
项目类别:
-
资助金额:$0.46万
-
财政年份:2009
-
负责人:CLARA KIELKOPF
-
依托单位:
REDOX-SENSING REPRESSOR
-
批准号:7726275
-
项目类别:
-
资助金额:$1.04万
-
财政年份:2008
-
负责人:CLARA KIELKOPF
-
依托单位:
PRE-MRNA SPLICE SITE RECOGNITION IN HUMAN DISEASE
-
批准号:7721332
-
项目类别:
-
资助金额:$3.77万
-
财政年份:2008
-
负责人:CLARA KIELKOPF
-
依托单位:
REDOX-SENSING REPRESSOR
-
批准号:7602342
-
项目类别:
-
资助金额:$0.82万
-
财政年份:2007
-
负责人:CLARA KIELKOPF
-
依托单位:
PROTEIN-PROTEIN INTERACTIONS AMONG PRE-MRNA SPLICING FACTORS
-
批准号:7182000
-
项目类别:
-
资助金额:$1.03万
-
财政年份:2005
-
负责人:CLARA KIELKOPF
-
依托单位:
Molecular Recognition during pre-mRNA Splicing
-
批准号:7413519
-
项目类别:
-
资助金额:$14.83万
-
财政年份:2004
-
负责人:CLARA KIELKOPF
-
依托单位:
Molecular Recognition during pre-mRNA Splicing
-
批准号:8103948
-
项目类别:
-
资助金额:$37.89万
-
财政年份:2004
-
负责人:CLARA KIELKOPF
-
依托单位:
Molecular Recognition during pre-mRNA Splicing
-
批准号:8696485
-
项目类别:
-
资助金额:$38.88万
-
财政年份:2004
-
负责人:CLARA KIELKOPF
-
依托单位:
Molecular Recognition during pre-mRNA Splicing
-
批准号:7473255
-
项目类别:
-
资助金额:$34.49万
-
财政年份:2004
-
负责人:CLARA KIELKOPF
-
依托单位:
Molecular Recognition During Pre-mRNA Splicing
-
批准号:10794795
-
项目类别:
-
资助金额:$4.93万
-
财政年份:2004
-
负责人:CLARA KIELKOPF
-
依托单位:
Molecular Recognition during pre-mRNA Splicing
-
批准号:7470369
-
项目类别:
-
资助金额:$7.74万
-
财政年份:2004
-
负责人:CLARA KIELKOPF
-
依托单位:
海外基金